The effects of SGLT-2 inhibitors vs renin-angiotensin-aldosterone system inhibition on cardiovascular outcomes of heart failure with preserved ejection fraction: network meta-analysis
Event:
Heart Failure 2022
Topic:
Pharmacotherapy
Session:
Heart Failure ePosters - focus on Chronic Heart Failure 1